New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.

Heart Disease and Cancer Vaccines by 2030?

Researchers believe 15 years of vaccine progress was achieved in 12-18 months due to the success of the COVID vaccine.

Screen Shot 2022 04 18 At 2 39 20 Pm
Getty Images

According to a recent article from The Guardian, mRNA vaccine technology has shown promising results in trials against cancer and heart disease. Researchers are optimistic that mRNA vaccines could be ready for public use by the end of the decade. The mRNA technology has already been successfully used in COVID-19 vaccines. The mRNA vaccines have the potential to be more effective than traditional vaccines because they can be tailored to an individual’s genetic makeup. This could lead to more personalized treatment and prevention of diseases. However, the vaccines are still in the early stages of development and more research is needed to confirm their effectiveness and safety.

How to Honor a Leader
Induction into the Packaging & Processing Hall of Fame is the highest honor in our industry. Submit your leader to be considered for the Class of 2024 now through June 10th. New members will be inducted at PACK EXPO International in Chicago.
Read More
How to Honor a Leader
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub